Jorge Gómez Tejeda Zañudo

11PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer geneticsMolecular targetsCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 13, 2025
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS).

Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li

|Dec 18, 2024
Count Me In: patient-partnered research to address disparities for rare cancer patients.

Priyanka Bhakhri, Kolbe Phelps, Jorge Gómez Tejeda Zañudo

|Oct 31, 2024
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.

Johanna Klughammer, Daniel L Abravanel, Åsa Segerstolpe

Pageof 2